Methods and compositions to graft bone using iron excipients
US-2024000996-A1 · Jan 4, 2024 · US
US11944716B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11944716-B2 |
| Application number | US-202117544544-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 7, 2021 |
| Priority date | Mar 30, 2018 |
| Publication date | Apr 2, 2024 |
| Grant date | Apr 2, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composition includes a plurality of particulate coated hydrogel microparticles, each of the microparticles including a hydrogel inner core and a particulate shell defined by a plurality of solid nanoparticles, the particulate shell inhibiting aggregation of the microparticles in an aqueous medium and being permeable to allow release of agents from the hydrogel inner core.
Opening claim text (preview).
Having described the invention, we claim: 1. A composition comprising: a plurality of particulate coated hydrogel microparticles, each of the microparticles including a hydrogel inner core and a particulate shell defined by a plurality of solid, inorganic nanoparticles, the hydrogel inner core comprising gelatin and at least one bioactive agent, and the particulate shell inhibiting aggregation of the microparticles in an aqueous medium and being permeable to allow release of bioactive agents provided in the hydrogel inner core from the hydrogel inner core, wherein the microparticles have an average diameter of about 25 μm to about 500 μm, and a plurality of cells, the cells being dispersed with the microparticles in the composition. 2. The composition of claim 1 , wherein the gelatin is at least partially cross-linked. 3. The composition of claim 1 , wherein the nanoparticles have an average diameter of about 1 nm to about 999 nm. 4. The composition of claim 1 , wherein the solid nanoparticles include silica nanoparticles.
Collagen · CPC title
Microcapsules {having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals (A61K9/2081 takes precedence; particles with a single coating comprising drug A61K9/167)} · CPC title
Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs (tablets containing such a mixture A61K9/2077) · CPC title
Inorganic compounds · CPC title
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.